flufenamic acid has been researched along with Cholera in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Cholera: An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flufenamic acid (FFA) has previously been demonstrated to be a potent activator of AMP-activated protein kinase (AMPK), which is a negative regulator of NF-κB signaling." | 5.46 | Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation. ( Chatsudthipong, V; Chittavanich, P; Kittayaruksakul, S; Muanprasat, C; Pongkorpsakol, P; Satitsri, S; Srimanote, P; Wongkrasant, P, 2017) |
| "Flufenamic acid (FFA) has previously been demonstrated to be a potent activator of AMP-activated protein kinase (AMPK), which is a negative regulator of NF-κB signaling." | 1.46 | Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation. ( Chatsudthipong, V; Chittavanich, P; Kittayaruksakul, S; Muanprasat, C; Pongkorpsakol, P; Satitsri, S; Srimanote, P; Wongkrasant, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pongkorpsakol, P | 1 |
| Satitsri, S | 1 |
| Wongkrasant, P | 1 |
| Chittavanich, P | 1 |
| Kittayaruksakul, S | 1 |
| Srimanote, P | 1 |
| Chatsudthipong, V | 1 |
| Muanprasat, C | 1 |
1 other study available for flufenamic acid and Cholera
| Article | Year |
|---|---|
Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation.
Topics: AMP-Activated Protein Kinases; Animals; Body Fluids; Calcium-Calmodulin-Dependent Protein Kinase Kin | 2017 |